Histopathology images predict multi-omics aberrations and prognoses in colorectal cancer patients
Tsai, Pei-Chen; Lee, Tsung-Hua; Kuo, Kun-Chi; Su, Fang-Yi; Lee, Tsung-Lu Michael; Marostica, Eliana; Ugai, Tomotaka; Zhao, Melissa; Lau, Mai Chan; Väyrynen, Juha P.; Giannakis, Marios; Takashima, Yasutoshi; Kahaki, Seyed Mousavi; Wu, Kana; Song, Mingyang; Meyerhardt, Jeffrey A.; Chan, Andrew T.; Chiang, Jung-Hsien; Nowak, Jonathan; Ogino, Shuji; Yu, Kun-Hsing (2023-04-13)
Tsai, PC., Lee, TH., Kuo, KC. et al. Histopathology images predict multi-omics aberrations and prognoses in colorectal cancer patients. Nat Commun 14, 2102 (2023). https://doi.org/10.1038/s41467-023-37179-4
© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
https://creativecommons.org/licenses/by/4.0/
https://urn.fi/URN:NBN:fi-fe20230906120693
Tiivistelmä
Abstract
Histopathologic assessment is indispensable for diagnosing colorectal cancer (CRC). However, manual evaluation of the diseased tissues under the microscope cannot reliably inform patient prognosis or genomic variations crucial for treatment selections. To address these challenges, we develop the Multi-omics Multi-cohort Assessment (MOMA) platform, an explainable machine learning approach, to systematically identify and interpret the relationship between patients’ histologic patterns, multi-omics, and clinical profiles in three large patient cohorts (n = 1888). MOMA successfully predicts the overall survival, disease-free survival (log-rank test P-value<0.05), and copy number alterations of CRC patients. In addition, our approaches identify interpretable pathology patterns predictive of gene expression profiles, microsatellite instability status, and clinically actionable genetic alterations. We show that MOMA models are generalizable to multiple patient populations with different demographic compositions and pathology images collected from distinctive digitization methods. Our machine learning approaches provide clinically actionable predictions that could inform treatments for colorectal cancer patients.
Kokoelmat
- Avoin saatavuus [32049]